About RNAi-Based Therapeutics Summit
As this community aims to make 2021 a landmark year for RNAi therapies, this meeting serves as a critical industry touchpoint, bringing you more speakers, expanded content, and a bespoke comprehensive platform.
5 Unmissable Highlights
Debate how to Optimize Effective Delivery Strategies
Consider next generation of delivery techniques beyond GalNac and debating effectivity of novel technologies with insights from University of Massachusetts Medical School & Avidity Biosciences
Explore Viability of RNAi Therapies Beyond the Liver
Discuss extrahepatic delivery techniques, demonstrating effective RNAi therapies within the CNS & lungs, with insight from Triplet Therapeutics & University of Munich
Discuss Effective Translation of RNAi Therapies to Patients
Outlining the important progression of RNAi therapies to the patient and discuss the vital considerations for an accessible therapy with insights from Alnylam, Olix Pharmaceuticals & AstraZenaca
Minimize Off-Target Effects & Enhance Targeted Delivery of RNAi
Explore how to alter the stability and efficiency of RNAi therapies and discuss endosomal escape methodologies with insights from Sapreme Technologies & University of Paris-Saclay
Harness Chemical Biology
From siRNA, microRNA & ASO’s, understand how best to leverage RNA for viable RNAi therapies with insight from Sanofi & Amgen